Manufacturer: Novo Nordisk (brand Victoza), Teva Pharmaceuticals/others (generic) Launch Date: 6/24/2023 On June 24, 2024, drug manufacturer Teva Pharmaceuticals announced the launch of an authorized generic formulation of Novo Nordisks Victoza (liraglutide)
As a lipid-soluble benzoquinone, CoQ10 plays dual roles in the metabolism of mitochondrial energy and antioxidant protection
Furthermore, metformin has been shown to improve endometrial tolerance through its actions on the mitochondrial respiratory chain, activation of AMPK, suppression of NF-B, AGE production, and downregulation of inflammatory pathways (Ye et al., 2018)
The connection between the two is profound
The standard therapeutic dose is 0.51.0mL subcutaneously once weekly, injected into the lower abdomen or lateral thigh with a 25G or 27G needle